Sotera Health (NASDAQ:SHC) Director Sells 12,000,000 Shares

Key Points

• A director at Sotera Health sold 12 million shares for a total of $181.32 million, reducing their stake by 16.26%.
• The company reported $0.20 earnings per share for the last quarter, exceeding analysts' expectations and reflecting a 6.4% increase in revenue year-over-year.
• Sotera Health currently holds a market cap of $4.49 billion and has a price-to-earnings ratio of 197.65.

Sotera Health Company (NASDAQ:SHC - Get Free Report) Director Pincus & Co. Warburg sold 12,000,000 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the completion of the transaction, the director owned 61,822,952 shares in the company, valued at $934,144,804.72. This represents a 16.26% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Sotera Health Trading Down 0.6%

Sotera Health stock traded down $0.10 during mid-day trading on Tuesday, reaching $15.81. 2,138,026 shares of the company traded hands, compared to its average volume of 2,409,231. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. The firm's 50 day moving average price is $13.52 and its 200 day moving average price is $12.37. The firm has a market capitalization of $4.49 billion, a price-to-earnings ratio of 197.65 and a beta of 1.84. Sotera Health Company has a 52-week low of $9.53 and a 52-week high of $16.99.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. The firm had revenue of $294.34 million for the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. On average, analysts anticipate that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Institutional Trading of Sotera Health

A number of institutional investors have recently bought and sold shares of SHC. UMB Bank n.a. grew its stake in Sotera Health by 112.8% in the second quarter. UMB Bank n.a. now owns 2,635 shares of the company's stock valued at $29,000 after purchasing an additional 1,397 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of Sotera Health by 3,690.1% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock worth $31,000 after acquiring an additional 2,620 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Sotera Health by 124.0% during the second quarter. Parallel Advisors LLC now owns 3,340 shares of the company's stock worth $37,000 after acquiring an additional 1,849 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Sotera Health by 831.4% during the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company's stock worth $37,000 after acquiring an additional 2,935 shares during the last quarter. Finally, Summit Securities Group LLC purchased a new stake in shares of Sotera Health during the first quarter worth about $67,000. 91.03% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

SHC has been the subject of several research reports. Barclays reissued an "overweight" rating on shares of Sotera Health in a report on Friday, August 8th. Wall Street Zen raised shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 16th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Sotera Health currently has an average rating of "Moderate Buy" and an average target price of $16.00.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.